# Electronic Letters to Improve Patient Activation in IHD: The NUDGE-IHD Trial

> **NCT07382414** · NA · NOT_YET_RECRUITING · sponsor: **Tor Biering-Sørensen** · enrollment: 100000 (estimated)

## Conditions studied

- Coronary Artery Disease
- Hypercholesterolemia
- Lipoprotein(a)
- Secondary Prevention

## Interventions

- **BEHAVIORAL:** LDL-C information letter
- **BEHAVIORAL:** Lp(a) information letter

## Key facts

- **NCT ID:** NCT07382414
- **Lead sponsor:** Tor Biering-Sørensen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 100000 (ESTIMATED)
- **Last updated:** 2026-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07382414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07382414, "Electronic Letters to Improve Patient Activation in IHD: The NUDGE-IHD Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07382414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*